"Neurology Consultants of Dallas has been in practice for over 25 years providing excellent neurological care in the DFW area. Our office is equipped with fellowship-trained neurologists that serve our patients with compassion. We strive to offer comprehensive, holistic centered care to those dealing with neurological disabilities. We provide patients with in-house diagnostic care, clinical research participation and much more!"

During the past decade, Neurology Consultants of Dallas, PA conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 8 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Neurology Consultants of Dallas, PA" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Impax Laboratories, LLC" with 2 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Neurology Consultants of Dallas, PA" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Neurology Consultants of Dallas, PA" are "Alzheimer Disease" (3 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (2 trials), "Parkinson Disease" (2 trials), "Parkinson's Disease" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Neurology Consultants of Dallas, PA" in a lesser frequency.

Most popular intervention types in "Neurology Consultants of Dallas, PA" are "Drug" (16 trials), "Other" (2 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "AVP-786" (2 trials), "PF-06649751" (2 trials), "Aspirin" (1 trials) and "BIIB080" (1 trials). Other intervention names were less common.

The vast majority of trials in "Neurology Consultants of Dallas, PA" are 17 trials for "All" genders.

Currently, there are NaN active trials in "Neurology Consultants of Dallas, PA". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Neurology Consultants of Dallas, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Neurology Consultants of Dallas, PA, 2 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Neurology Consultants of Dallas, PA has several departments that took part in Clinical trials: "Neurology Consultants of Dallas; Research Department" - 2 trials